Volume 10, Number 3, May-June 2003

Prevalence and risks of undertreatment with statins
Adrian J Brady, D John Betteridge

Statins are prescribed worldwide for patients with coronary heart disease (CHD) and also for those at risk of developing atherosclerotic vascular disease. This article looks at the prescribing of statins in the UK demonstrating how they are underprescribed in this country, how ineffective doses of statins are used due to many doctors not understanding how to implement guidelines, and how the greatest reductions in CHD risk are achieved by the greatest reductions in cholesterol.

Br J Cardiol 2003;10:218-219.

View full PDF article (open in new window)
Email this article